RNA sequencing–based determination of the RNA interactome of wild-type AKAP1 and its deletion mutants deficient for the KH or Tudor domain.
Ontology highlight
ABSTRACT:
INSTRUMENT(S): Illumina NovaSeq 6000
ORGANISM(S): Homo sapiens
SUBMITTER: Domenico Memoli
PROVIDER: E-MTAB-16473 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Similar Datasets
Project description:Processing (P)-bodies are cytoplasmic membrane-less condensates including translationally repressed mRNAs and proteins involved in the mRNA decay machinery. The mechanisms underlying P-bodies nucleation and mRNA decay have been largely described. However, the impact of signaling networks in P-bodies dynamics and mRNA translation is still not well understood. Here, we identify a ribonucleoprotein network assembled by the E3 ubiquitin ligase Praja2 at P-bodies that coordinates protein translation and mRNA turnover in human glioblastoma (GBM). Praja2 physically interacts and spatially colocalizes with the RNA helicase DDX6, a core component and nucleating factor of P-bodies. Stimulation of the G protein-coupled receptor (GPCR)-cAMP pathway in GBM cells induces a non-proteolytic polyubiquitylation of DDX6 by Praja2. DDX6 ubiquitylation is required for P-bodies assembly and mRNA translation repression. Interfering with DDX6 ubiquitylation or downregulation of expression markedly affects P-bodies assembly. Moreover, genetic deletion of praja2 dramatically impacts the assembly of DDX6/mRNA complexes and the amount of translating polysomes, leading to cellular senescence and GBM growth arrest. These findings identify a cAMP-driven post-transcriptional control mechanism operating at P-bodies by the ubiquitin system that profoundly impacts on mRNA translation and cancer cell growth. This regulatory system may, thus, contribute to the adaptive metabolic rewiring underlying cancer growth and drug resistance.
2025-03-30 | E-MTAB-14331 | biostudies-arrayexpress
Project description:Processing (P)-bodies are cytoplasmic membrane-less condensates including translationally repressed mRNAs and proteins involved in the mRNA decay machinery. The mechanisms underlying P-bodies nucleation and mRNA decay have been largely described. However, the impact of signaling networks in P-bodies dynamics and mRNA translation is still not well understood. Here, we identify a ribonucleoprotein network assembled by the E3 ubiquitin ligase Praja2 at P-bodies that coordinates protein translation and mRNA turnover in human glioblastoma (GBM). Praja2 physically interacts and spatially colocalizes with the RNA helicase DDX6, a core component and nucleating factor of P-bodies. Stimulation of the G protein-coupled receptor (GPCR)-cAMP pathway in GBM cells induces a non-proteolytic polyubiquitylation of DDX6 by Praja2. DDX6 ubiquitylation is required for P-bodies assembly and mRNA translation repression. Interfering with DDX6 ubiquitylation or downregulation of expression markedly affects P-bodies assembly. Moreover, genetic deletion of praja2 dramatically impacts the assembly of DDX6/mRNA complexes and the amount of translating polysomes, leading to cellular senescence and GBM growth arrest. These findings identify a cAMP-driven post-transcriptional control mechanism operating at P-bodies by the ubiquitin system that profoundly impacts on mRNA translation and cancer cell growth. This regulatory system may, thus, contribute to the adaptive metabolic rewiring underlying cancer growth and drug resistance.
2025-03-30 | E-MTAB-14328 | biostudies-arrayexpress
Project description:Glioblastoma (GBM) is a malignant grade IV brain tumor, and despite the multimodal therapeutic approaches, which include surgery and chemo-radiotherapy, recurrence is inevitable, arising from therapy-resistant residual cells. To study the residual population's survival mechanism(s), we established a radiation survival model from GBM cells and primary patient cultures (parent or P). Interestingly, the residual cells (RS), although non-proliferative and enriched in multinucleated and giant cell phenotype (MNGCs) phenotype, underwent unconventional cell division (end of residual or ERS phase) in the absence of spindle structures and cytokinesis to generate aggressive relapse (R). RNA sequencing of GBM cell line U87MG and patient sample 2 (PS2) at different time points post-radiation treatment was performed to understand the molecular players behind this residual cell division.
2025-08-15 | E-MTAB-14162 | biostudies-arrayexpress
Project description:miR-137 plays critical roles in the nervous system and tumor development. An increase in its expression is required for neuronal differentiation while its reduction is implicated in gliomagenesis. To evaluate the potential of miR-137 in glioblastoma therapy, we conducted genome-wide target mapping in glioblastoma cells by measuring levels of associations between PABP and mRNAs in cells transfected with miR-137 mimics vs. controls via RIPSeq. Impact on mRNA levels was also measured by RNASeq. By combining the results of both experimental approaches, 1468 genes were determined to be negatively impacted by miR-137; among them, 595 (40%) contain miR-137 predicted sites. The most relevant targets include oncogenic proteins and players in neurogenesis like c-KIT, YBX1, AKT2, CDC42, CDK6 and TGFβ2. Interestingly, we observed that several identified miR-137 targets are also predicted to be regulated by miR-124, miR-128 and miR-7, which are equally implicated in neuronal differentiation and gliomagenesis. We suggest that the concomitant increase of these four miRNAs in neuronal stem cells or their repression in tumor cells could produce a robust regulatory effect with major consequences to neuronal differentiation and tumorigenesis. Identification of genes affected by miR137 transfection via RIP-Seq and RNA-Seq in U251 and U343 cells
2014-02-11 | E-GEOD-53220 | biostudies-arrayexpress
Project description:Despite considerable evidence that RNA-binding proteins (RBPs) regulate mRNA transport and local translation in dendrites, roles for axonal RBPs are poorly understood. Here we demonstrate that a nontelomeric isoform of telomere repeat-binding factor 2 (TRF2-S) is a novel RBP that regulates axonal plasticity. TRF2-S interacts directly with target mRNAs to facilitate their axonal delivery. The process is antagonized by fragile X mental retardation protein (FMRP). Distinct from the current RNA-binding model of FMRP, we show that FMRP occupies the GAR domain of TRF2-S protein to block the assembly of TRF2-S-mRNA complexes. Overexpressing TRF2-S and silencing FMRP promotes mRNA entry to axons, and enhances axonal outgrowth and neurotransmitter release from presynaptic terminals. Our findings suggest a pivotal role for TRF2-S in an axonal mRNA localization pathway that enhances axon outgrowth and neurotransmitter release. RNA immunoprecipitated samples using either anti-rat TRF2-S or rabbit IgG antibodies were used to generate biotin-labeled RNA using the Illumina Total Prep RNA Amplification Kit (Ambion), which was hybridized to Illumina's rat Ref-12 Expression BeadChips (Illumina, San Diego, CA), containing 22,523 well-annotated RefSeq transcripts with ~30-fold redundancy. The arrays were scanned using an Illumina BeadStation 500X Genetic Analysis Systems scanner and the image data extracted using Illumina BeadStudio software, version 1.5, normalized by Z-score transformation and used to calculate differences in signal intensities. Significant values were calculated from two groups of independent experiments, using a two-tailed Z-test with P < 0.05, a false discovery rate <0.30, a z ratio absolute value not less than 1.5, and an average signal intensity not less than zero. The results also had to pass the filtering and one-way independent ANOVA test by sample groups less than 0.05, and detection p-value for any probe in the comparison group less than 0.02.
2015-11-06 | E-GEOD-72887 | biostudies-arrayexpress
Project description:Processing (P)-bodies are cytoplasmic membrane-less condensates including translationally repressed mRNAs and proteins involved in the mRNA decay machinery. The mechanisms underlying P-bodies nucleation and mRNA decay have been largely described. However, the impact of signaling networks in P-bodies dynamics and mRNA translation is still not well understood. Here, we identify a ribonucleoprotein network assembled by the E3 ubiquitin ligase Praja2 at P-bodies that coordinates protein translation and mRNA turnover in human glioblastoma (GBM). Praja2 physically interacts and spaBally co-localizes with the RNA helicase DDX6, a core component and nucleating factor of P-bodies. Stimulation of the G protein-coupled receptor (GPCR)-cAMP pathway in GBM cells induces a non-proteolytic polyubiquitylation of DDX6 by Praja2. DDX6 ubiquitylation is required for P-bodies assembly and mRNA translation repression. Interfering with DDX6 ubiquitylation or downregulation of expression markedly affects P-bodies assembly. Moreover, geneBc deleBon of praja2 dramatically impacts the assembly of DDX6/mRNA complexes and the amount of translating polysomes, leading to cellular senescence and GBM growth arrest. These findings identify a cAMP-driven post-transcriptional control mechanism operating at P- bodies by the ubiquitin system that profoundly impacts on mRNA translation and cancer cell growth. This regulatory system may, thus, contribute to the adaptive metabolic rewiring underlying cancer growth and drug resistance.
2025-03-30 | E-MTAB-14326 | biostudies-arrayexpress
Project description:For identification of proteins that associate with Makorin1 (MKRN1) in RNA-dependent and RNA-independent manners, we affinity purified FLAG-tagged Makorin1 (MKRN1) from mouse embryonic stem cells constitutively expressing FLAG:MKRN1. Anti-FLAG control immunoprecipitations were performed from a FLAG vectrol control (FLAG:Ctrl) mouse embryonic stem cell line that did not express FLAG:MKRN1. Following FLAG immunoprecipitation, anti-FLAG beads from FLAG:MKRN1 and FLAG:Ctrl immunoprecipitations were split into separate tubes such that half of the beads were digested with 200Ã∞â≈ Ã≠µg/mL RNase A while the other half of the beads were undigested. RNase A-digested and undigested immunoprecipitates were subjected to LC-MS/MS analysis. Of the 48 RNA-related proteins previously identified to associate with FLAG:MKRN1, L1TD1, PABPC1, PABPC4, YBX1, IGF2BP1 and UPF1 were found to remain associated with FLAG:MKRN1 in the presence of RNase A.
2015-07-21 | PXD001291 | Pride
Project description:AEBP1 has been identified as a transcriptional repressor playing a significant role in adipogenesis. Recently, we have found that AEBP1 is specifically upregulated in primary glioblastoma. We have used gene silencing to identify genes perturbed upon AEBP1 downregulation and ChIP-chip technique to identify its genomic targets of binding and regulation to understand the un-annotated/undescribed role of this transcription factor in gliomagenesis. Cells either mock silenced or silenced using siRNA against AEBP1 were harvested at 46hrs post transfection. Gene expression was profiled for control and AEBP1 silenced cells. comparison of AEBP1/Rabbit IgG/ Glial cells
2012-04-29 | E-GEOD-18892 | biostudies-arrayexpress
Project description:Dendritic cell (DC)-based immunotherapy against glioblastoma multiforme is a novel treatment hope. Glioblastoma stem-like cells are, however, potentially causing immunoresistance. Glioblastoma cells cultured as gliomaspheres show a stem-like phenotype as opposed to classical adherent culture. They are thus a promising antigen source to specifically target glioblastoma stem-like cells via DC therapy and so overcome immunoresistance. Here we study the importance of gliomasphere-specific. Methodologically, we used 7 gliomaspheres, 3 of them patient-derived, as model system. Gliomasphere-specific protein expression was explored via quantitative proteomics.
2019-04-15 | PXD008244 | Pride
Project description:The dysregulated energy metabolism of glioblastoma cells is a critical factor in tumor development and progression. Lysine acetylation, regulated by the mitochondrial enzyme SIRT3, is known to play a key role in the metabolic phenotype of glioblastoma. To better understand how SIRT3 regulates mitochondrial metabolism, we inhibited SIRT3 and examined the proteome and acetylome of two glioblastoma cell lines with different metabolic preferences. Our results indicate that protein synthesis machineries are regulated by lysine acetylation and play a role in the metabolic phenotype. We also identified new SIRT3 targets that have not been previously associated with specific functions, highlighting their potential as future targets for further study. These findings enhance our understanding of the complex regulation of energy metabolism in glioblastoma and provide potential targets for future therapies.
2024-05-23 | PXD045197 | Pride